These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10465538)
1. Derivatives of (R)-2-amino-5-methoxytetralin: antagonists and inverse agonists at the dopamine D2A receptor. Höök BB; Brege C; Linnanen T; Mikaels A; Malmberg A; Johansson AM Bioorg Med Chem Lett; 1999 Aug; 9(15):2167-72. PubMed ID: 10465538 [TBL] [Abstract][Full Text] [Related]
2. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding. Malmberg ; Mikaels ; Mohell N J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001 [TBL] [Abstract][Full Text] [Related]
3. Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist. Dubuffet T; Newman-Tancredi A; Cussac D; Audinot V; Loutz A; Millan MJ; Lavielle G Bioorg Med Chem Lett; 1999 Jul; 9(14):2059-64. PubMed ID: 10450981 [TBL] [Abstract][Full Text] [Related]
4. Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays. Gilliland SL; Alper RH Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):498-504. PubMed ID: 10832603 [TBL] [Abstract][Full Text] [Related]
5. Novel (R)-2-amino-5-fluorotetralins: dopaminergic antagonists and inverse agonists. Malmberg A; Höök BB; Johansson AM; Hacksell U J Med Chem; 1996 Oct; 39(22):4421-9. PubMed ID: 8893836 [TBL] [Abstract][Full Text] [Related]
6. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain. Sóvágó J; Makkai B; Gulyás B; Hall H Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196 [TBL] [Abstract][Full Text] [Related]
7. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release. Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes. Rinken A; Finnman UB; Fuxe K Biochem Pharmacol; 1999 Jan; 57(2):155-62. PubMed ID: 9890563 [TBL] [Abstract][Full Text] [Related]
9. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists. Liu Y; Yu H; Mohell N; Nordvall G; Lewander T; Hacksell U J Med Chem; 1995 Jan; 38(1):150-60. PubMed ID: 7530773 [TBL] [Abstract][Full Text] [Related]
10. Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors. Terasmaa A; Finnman UB; Owman C; Ferré S; Fuxe K; Rinken A Neurosci Lett; 2000 Feb; 280(2):135-8. PubMed ID: 10686396 [TBL] [Abstract][Full Text] [Related]
11. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile. Gilliland SL; Alper RH; Levant B Eur J Pharmacol; 2000 Mar; 392(3):125-8. PubMed ID: 10762663 [TBL] [Abstract][Full Text] [Related]
13. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors. Wicke K; Garcia-Ladona J Eur J Pharmacol; 2001 Jul; 424(2):85-90. PubMed ID: 11476753 [TBL] [Abstract][Full Text] [Related]
14. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor. Pregenzer JF; Alberts GL; Im WB Neurosci Lett; 1997 Apr; 226(2):91-4. PubMed ID: 9159497 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors. Roberts DJ; Lin H; Strange PG Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865 [TBL] [Abstract][Full Text] [Related]
16. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes. Odagaki Y; Toyoshima R Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386 [TBL] [Abstract][Full Text] [Related]
17. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs. Wurch T; Boutet-Robinet EA; Palmier C; Colpaert FC; Pauwels PJ J Pharmacol Exp Ther; 2003 Jan; 304(1):380-90. PubMed ID: 12490615 [TBL] [Abstract][Full Text] [Related]
18. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists. Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156 [TBL] [Abstract][Full Text] [Related]
19. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment. Geurts M; Hermans E; Maloteaux JM Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146 [TBL] [Abstract][Full Text] [Related]
20. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]